Table of Contents
ISRN Hematology
Volume 2013, Article ID 236374, 5 pages
http://dx.doi.org/10.1155/2013/236374
Clinical Study

Addition of Multimodal Therapy to Standard Management of Steady State Sickle Cell Disease

1Department of Haematology, University of Nigeria Teaching Hospital, Enugu 46000, Nigeria
2Department of Haematology, College of Medicine, University of Nigeria, Enugu Campus, Nigeria
3Department of Paediatrics, University of Nigeria Teaching Hospital, Enugu 46000, Nigeria

Received 18 July 2013; Accepted 30 September 2013

Academic Editors: W. Fiedler and T. Ikuta

Copyright © 2013 Iheanyi Okpala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Tomer, S. Kasey, W. E. Connor, S. Clark, L. A. Harker, and J. R. Eckman, “Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids,” Thrombosis and Haemostasis, vol. 85, no. 6, pp. 966–974, 2001. View at Google Scholar · View at Scopus
  2. I. Okpala, O. Ibegbulam, A. Duru et al., “Pilot study of omega-3 fatty acid supplements in sickle cell disease,” Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 119, no. 7, pp. 442–448, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. A. Daak, K. Ghebremeskel, Z. Hassan et al., “Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial,” The American Journal of Clinical Nutrition, vol. 97, no. 1, pp. 37–44, 2013. View at Publisher · View at Google Scholar
  4. A. Cerami, “Cyanate as an inhibitor of red-cell sickling,” The New England Journal of Medicine, vol. 287, no. 16, pp. 807–812, 1972. View at Google Scholar · View at Scopus
  5. M. H. Steinberg and R. P. Hebbel, “Clinical diversity of sickle cell anemia: genetic and cellular modulation of disease severity,” American Journal of Hematology, vol. 14, no. 4, pp. 405–416, 1983. View at Google Scholar · View at Scopus
  6. P. W. Thomas, D. R. Higgs, and G. R. Serjeant, “Benign clinical course in homozygous sickle cell disease: a search for predictors,” Journal of Clinical Epidemiology, vol. 50, no. 2, pp. 121–126, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Taga, V. A. S. Oumbe, R. Johns, M. A. Zaidi, N. J. Yonkeu, and I. Altosaar, “Youth of West Cameroon are at high risk of developing IDD due to low dietary iodine and high dietary thiocyanate,” African Health Sciences, vol. 8, no. 4, pp. 227–233, 2008. View at Google Scholar · View at Scopus
  8. I. Okpala, “Leukocyte adhesion and the pathophysiology of sickle cell disease,” Current Opinion in Hematology, vol. 13, no. 1, pp. 40–44, 2006. View at Google Scholar · View at Scopus
  9. N. M. Matsui, L. Borsig, S. D. Rosen, M. Yaghmai, A. Varki, and S. H. Embury, “P-selectin mediates the adhesion of sickle erythrocytes to the endothelium,” Blood, vol. 98, no. 6, pp. 1955–1962, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. P. C. Calder, “Dietary fatty acids and lymphocyte function,” Proceedings of the Nutrition Society, vol. 57, no. 4, pp. 487–502, 1998. View at Google Scholar · View at Scopus
  11. H. Ren, I. Obike, I. Okpala, K. Ghebremeskel, C. Ugochukwu, and M. Crawford, “Steady-state haemoglobin level in sickle cell anaemia increases with an increase in erythrocyte membrane n-3 fatty acids,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 72, no. 6, pp. 415–421, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Ren, I. Okpala, K. Ghebremeskel, C. C. Ugochukwu, O. Ibegbulam, and M. Crawford, “Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease,” Annals of Hematology, vol. 84, no. 9, pp. 578–583, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J. J. M. Van den Berg, N. J. de Fouw, F. A. Kuypers, B. Roelofsen, U. M. T. Houtsmuller, and J. A. F. Op den Kamp, “Increased n-3 polyunsaturated fatty acid content of red blood cells from fish oil-fed rabbits increases in vitro lipid peroxidation, but decreases hemolysis,” Free Radical Biology and Medicine, vol. 11, no. 4, pp. 393–399, 1991. View at Publisher · View at Google Scholar · View at Scopus
  14. C. C. Anyaegbu, I. E. Okpala, Y. A. Aken’Ova, and L. S. Salimonu, “Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia (SCA),” European Journal of Haematology, vol. 60, no. 4, pp. 267–268, 1998. View at Google Scholar · View at Scopus
  15. O. S. Platt, D. J. Brambilla, W. F. Rosse et al., “Mortality in sickle cell disease—life expectancy and risk factors for early death,” The New England Journal of Medicine, vol. 330, no. 23, pp. 1639–1644, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. M. H. Steinberg and G. P. Rodgers, “Pathophysiology of sickle cell disease: role of genetic and cellular modifiers,” Seminars in Hematology, vol. 38, pp. 229–306, 2001. View at Google Scholar
  17. D. R. Powars, “β(S)-gene-cluster haplotypes in sickle cell anemia: clinical and hematologic features,” Hematology/Oncology Clinics of North America, vol. 5, no. 3, pp. 475–493, 1991. View at Google Scholar · View at Scopus